Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
ENSC
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comNEGATIVO
Ensysce Biosciences Announces Upcoming Conference and Industry Event Participation
SAN DIEGO, CA / ACCESS Newswire / September 2, 2026 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company") a clinical-stage biotechnology company developing novel neuroplastogenic therapies beyond mood disorders, with an in…
Eupraxia Pharmaceuticals Appoints New Technical Operations Heads; Co-Founder Malone Steps Down
(RTTNews) - Eupraxia Pharmaceuticals Inc. (EPRX), a clinical-stage biotechnology company, announced several leadership changes within the company to support its upcoming planned phase of clinical and commercial growth. The company appointe…
Ensyce Reports Extension Of Patent On MPAR To Prevent Opioid Abuse
(RTTNews) - Ensyce Biosciences Inc. (ENSC), a clinical-stage pharmaceutical company, on Thursday announced the expansion of a patent on its MPAR technology for preventing drug abuse, issued by the U.S. patent and trademark office (USPTO).…
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Quantum Cyber (NASDAQ:QUCY) shares increased by 55.0% to $0.5 during Wednesday's pre-market session. The market value of their outstanding shares is at $4.0 million. SELLAS Life Sciences Gr (NASDAQ:SLS) shares increased by 21.26% t…
Update: Wall Street Set to Open Lower Friday as Investors Analyze Higher Than Expected Producer Prices; Oil Prices Surge
(Updates to add ticker symbols in the symbol box.) US stocks look set to open lower in Friday's PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news a…
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change NVIDIA Corp. 306,426,752 182.59 176.38 177.19 -7.70 Ensysce Biosciences In…
Diamond Equity Research Releases Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC)
New York, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC). The research…
Diamond Equity Research Releases Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC)
New York, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC). The update n…
Ensysce Biosciences Accelerates PF614-MPAR-102 Study with Full Enrollment of Part 2
~ Treatment to Evaluate Effect of Food on Overdose Protection of MPAR ~ ~ Grant Funds from NIDA Accelerating Clinical Development Program ~ SAN DIEGO, CALIFORNIA / ACCESS Newswire / June 24, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) (…
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.59%
Investing.com – U.S. stocks were mixed after the close on Thursday, as gains in the Oil&Gas, Industrials and Basic Materials sectors led shares higher while losses in the Technology, Telecoms and Consumer Services sectors led shares lower.…
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.02%
Investing.com – U.S. stocks were higher after the close on Tuesday, as gains in the Financials, Technology and Telecoms sectors led shares higher. At the close in NYSE, the Dow Jones Industrial Average rose 0.02% to hit a new all time high…
In this piece, we will take a look at ten stocks targeted by short sellers recently. For more stocks, head on over to 5 Stocks Targeted By Short Sellers Recently. A curious outcome of the turmoil ushered in by the coronavirus pandemic was…
In this piece, we will take a look at ten penny stocks with insider buying. For more penny stocks, head on over to 5 Penny Stocks with Insider Buying. With the first quarter of 2023 coming to an end, the stock market continues to be in a t…
Diamond Equity Research to Host Spotlight Emerging Growth Invitational Virtual Investor Conference on January 25, 2023
Presenting Companies to Host 25 Minute Presentations Followed by Question-and-Answer Session; Conference Open to all Retail and Institutional Investors NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading small-ca…
Diamond Equity Research to Host Spotlight Emerging Growth Invitational Virtual Investor Conference on January 25, 2023
NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading small-capitalization equity research and conference provider, will host its Spotlight Emerging Growth Invitational Investor Conference on January 25, 2023. The…
Diamond Equity Research Initiates Coverage on Ensysce Biosciences, Inc. (NASDAQ: ENSC)
NEW YORK, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has initiated coverage of Ensysce Biosciences, Inc. (NASDAQ: ENSC). The in-depth 21-p…
Ensysce Biosciences Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
SAN DIEGO, March 31, 2022 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company applying transformative chemistry to improve prescription drug safety and per…
Ensysce Biosciences Announces Participation in the 34th Annual Roth Conference
SAN DIEGO, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company applying transformative chemistry to improve prescription drug safety and perf…
Ensysce Biosciences Appoints Industry Veteran Lee Rauch to Board of Directors
SAN DIEGO, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company applying transformative chemistry to improve prescription drug safety and perf…
Ensysce Biosciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communication Program
SAN DIEGO, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company with two novel technology platforms designed to provide relief for those suffe…
Ensysce Biosciences Announces Results of Special Meeting of Stockholders
SAN DIEGO, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company with two novel technology platforms designed to provide relief for those suffe…
Ensysce Biosciences Reminds Stockholders to Vote at Upcoming Special Meeting
SAN DIEGO, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company with novel technology platforms that may provide new hope for those in severe…
Short Squeeze Stocks: ISIG, RELI and 3 Others Experts Think Are Ready to Pop
Today, short squeeze stocks are in focus for investors. Indeed, a range of short squeeze hopefuls are once again grabbing attention. Those looking for the next GameStop (NYSE:GME) or AMC Entertainment (NYSE:AMC) may be intrigued by the pri…
Ensysce Biosciences Announces First Cohort Dosing in Bioequivalence (BE) Study of Novel “TAAP” Opioid
SAN DIEGO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company with two novel technology platforms designed to provide relief for those suffe…
Ensysce Biosciences Announces Participation in the H.C. Wainwright BIOCONNECT Conference
SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company with novel technology platforms that may provide new hope for those in severe…
Ensysce Biosciences Achieves Successful Completion of Part A of Multiple-Ascending Dose (MAD)/Bioequivalents (BE) Trial for its Next Generation Opioid, PF614
SAN DIEGO, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company with novel technologies that may provide new hope for those in severe pain, to…
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning, investor! We’ve reached the halfway point of the week and we’re starting it with an overview of the biggest pre-market stock movers for Wednesday! A close-up shot of the Wall Street street sign representing Pre-Market Stock M…
Ensysce Biosciences Announces First Patients Enrolled in Phase 1 Study of PF614-MPAR™, its unique technology platform to provide opioid overdose protection
SAN DIEGO, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company with novel technology platforms that may provide new hope for those in severe…
BYDDF Stock: 10 Things to Know About BYD as Investors Hunt for the Next Hot EV Play
BYD (OTCMKTS:BYDDF) stock is on the move today despite a lack of news concerning the electric vehicle (EV) company. A close-up view of the power supply plugged into a vehicle from BYD Company (BYDDF stock). Source: J. Lekavicius / Shutters…
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Good morning, trader! It’s time to kick off another busy day of trading with the biggest pre-market stock movers for Thursday! top stocks: skyscraper buildings viewed from the ground with Wall Street street sign in the foreground represent…
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning, trader! We’ve reached the halfway point of the week and there’s no slowing down as we dive into the biggest pre-market stock movers for Wednesday! A view of the Federal Hall on Wall Street representing Pre-Market Stock Movers…
Ensysce Biosciences Announces Clinical Trial Progress of its New Class of Opioids
SAN DIEGO, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company with novel technologies that may provide new hope for those in severe pain, to…
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning, trader! We’re halfway through the week and with that comes a look at the biggest pre-market stock movers for Wednesday! A view of the Federal Hall on Wall Street representing Pre-Market Stock Movers. Source: f11photo/Shutters…
Ensysce Biosciences Reports Third Quarter 2021 Financial Results and Recent Corporate Updates
SAN DIEGO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company with proprietary technology platforms to reduce the economic and social burden…